Clinical Trial Update: A Novel Blood Test as a Biomarker in Mental Health

View source ↗

Summary

This clinical trial investigates a novel blood test biomarker for mental health conditions. The study (NCT06856161) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Anxiety Disorders
• Bipolar Disorder
• Major Depressive Disorder
• Psychotic Disorders
• Schizophrenia
• Substance Use Disorder

Snippet

Sponsor: Fraser Health | Conditions: Depression - Major Depressive Disorder, Schizophenia Disorder | Status: RECRUITING